Replicative Stress in Hair Follicle Stem Cells and Pathogeny of Hidradenitis Suppurativa
NCT05531747 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2025-02-06
Summary
Hidradenitis Suppurativa is a recurrent chronic inflammatory follicular occlusive disease affecting hair follicles. HS is notoriously difficult and challenging to treat with a high morbidity impact and could be classified as an unmet medical need with no efficient therapeutic options.
Objective:
Investigators previously showed that Outer Root Sheath Cells (ORS) isolated from hair follicle of HS patients (HS-ORS) have a pro-inflammatory phenotype and secrete spontaneously IP-10 and RANTES. To identify the mechanisms involved in the pro-inflammatory phenotype of HS-ORS, investigators performed a transcriptomic analysis in healthy and HS patients. This revealed: (i) an IFN signature, (i) a dysregulation of genes involved in cell proliferation and differentiation, and (iii) an upregulation of DNA damage response and cell cycle G2/M checkpoint pathways in HS-ORS. These findings support the notion that, in HS patients, a perturbation of HF-SC homeostasis leading to an increased proliferation induces a replicative stress and an accumulation of cytoplasmic ssDNA, stimulating IFN synthesis through IFI16-STING pathway. Interestingly, replicative stress in ORS were present in some but not all patients with Hidradenitis Suppurativa. The goal of study is to determine replicative stress in ORS in a large cohort of HS patients.
Method Patients will be enrolled in the Mondor Dermatology department, during routine care. A dermatologist will check all inclusion and exclusion criteria with the technical support of a research technician of the Henri Mondor Clinical Investigation Center. Medical history, clinical data, comorbidities and concomitant therapies will be prospectively recorded in a dedicated case report form. Skin biopsies will be performed in perilesional zone rich in hair follicles. mRNA will be extracted from freshly isolated hair follicle cells and some slides will be prepared and stored at -80°C to perform immunohistochemistry analysis on freshly isolated hair follicle cells. PBMC and serum will be collected.
All these biological samples will allow us to quantify the replicative stress in HS-ORS of each patient, and to quantify several cytokine of interest : IFN de type 1, IL-17, IL-6, TNF-α, IL-10
This study will allow investigators to evaluate the rate of patients with replicative stress in hair follicle stem cells in Hidradenitis Suppurativa. The investigator will also determine whether HF-SC replication stress correlates with clinical characteristics and/or with clinical course and/or comorbidities.
Conditions
Interventions
- OTHER
-
Skin biopsy
A maximum of 2 superficial skin biopsies (epidermis/dermis), allowing 10 hair follicles to be obtained, at the edge of the affected area, in healthy territory (excluding the face and folds but not excluding the pubic region), at initiation visit.
- OTHER
-
Blood sample
42mL of blood (6 tubes of 7mL) sampled at initiation visit
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-13
- Primary Completion
- 2029-06-13
- Completion
- 2029-12-13
Countries
- France
Study Locations
More Related Trials
-
Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation
NCT06145672 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
NCT02793557 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
NCT01501617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
NCT01451151 ·Status: COMPLETED ·Phase: PHASE2
-
Hair Regrowth After Bicoronal Incision
NCT01557491 ·Status: UNKNOWN ·Phase: NA
-
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
NCT00691769 ·Status: COMPLETED
-
Safety and Efficacy of HST 001 in Male Pattern Hair Loss
NCT04435847 ·Status: COMPLETED ·Phase: PHASE1
-
a Retrospective Study on the Systemic Treatment of LPP and FFA
NCT06512766 ·Status: COMPLETED
-
Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia
NCT01286649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tissue Engineering for Hair Follicle Regeneration
NCT00506636 ·Status: UNKNOWN
-
Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis
NCT03491267 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
NCT00177099 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in Subjects With Mild to Moderate Hair Thinning.
NCT07195487 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss
NCT01451021 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)
NCT01451112 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
NCT06202560 ·Status: COMPLETED ·Phase: NA
-
Cryopreserved Hair Follicles for Disease and Cell Replacement
NCT06764719 ·Status: RECRUITING
-
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
NCT07029711 ·Status: RECRUITING ·Phase: PHASE3
-
Fractional Photothermolysis for Hair Follicle Induction
NCT03382184 ·Status: TERMINATED ·Phase: NA
-
Treatment of Alopecia Using Follicular Stem Cells
NCT05210452 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Topical Finasteride in the Treatment of Idiopathic Hirsutism
NCT00564252 ·Status: COMPLETED ·Phase: NA
-
Natural History and Pathogenesis of Alopecia in Children and Adults
NCT05502796 ·Status: COMPLETED
-
AGA Biocellular Stem/Stromal Hair Regenerative Study
NCT02849470 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
NCT03467412 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
NCT01451177 ·Status: COMPLETED ·Phase: PHASE2